Domino’s Pizza (DPZ) is down 3.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a mix of lingering concern over soft underlying sales trends and a fresh analyst downgrade earlier this week. While Domino’s posted revenue growth in its latest quarter, investors appear focused on weak same-store sales and signs that demand remains uneven, which can pressure sentiment after a recent rally.

Details:

  • Domino’s latest quarterly release showed U.S. same-store sales growth of just 0.1%, while international same-store sales slipped 0.1%, pointing to a relatively muted top-line demand picture.
  • Second-quarter revenue rose 4.3% year over year, but adjusted investor attention appears to have centered more on traffic quality and comparable-sales momentum than on overall revenue growth.
  • The company reported diluted EPS of $4.07 in the quarter, below the consensus figure tracked in market coverage, which may have reinforced concerns that operating performance was not strong enough to support a higher valuation.
  • A recent Baird downgrade to Neutral with a $350 price target likely added pressure, especially with the stock having rebounded after the earnings release.
  • Sources:

    Domino’s Pizza Investor Relations, SEC, Benzinga

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $DPZ Insider Trading Activity

    DPZ Insider Trades

    $DPZ insiders have traded $DPZ stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.

    Here’s a breakdown of recent trading of $DPZ stock by insiders over the last 6 months:

    • KELLY E GARCIA (EVP, Chief Tech & Data Ofcr) has made 0 purchases and 11 sales selling 14,380 shares for an estimated $4,614,429.
    • RUSSELL J WEINER (Chief Executive Officer) sold 10,850 shares for an estimated $3,589,505
    • JOSEPH HUGH JORDAN (COO and President-Domino’s US) has made 0 purchases and 2 sales selling 5,450 shares for an estimated $1,696,530.
    • REDDY SANDEEP (EVP, Chief Financial Officer) has made 0 purchases and 4 sales selling 3,519 shares for an estimated $1,403,239.
    • CYNTHIA A HEADEN (EVP, Chief Supply Chain Offr) has made 0 purchases and 2 sales selling 2,483 shares for an estimated $989,919.
    • JESSICA L PARRISH has made 0 purchases and 4 sales selling 665 shares for an estimated $265,216.
    See also  Co-Diagnostics Q2 Revenue Rises: International Expansion Drives Growth

    To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $DPZ Hedge Fund Activity

    We have seen 376 institutional investors add shares of $DPZ stock to their portfolio, and 536 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • BERKSHIRE HATHAWAY INC removed 3,350,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,201,946,500
    • FMR LLC added 1,568,880 shares (+61.1%) to their portfolio in Q2 2026, for an estimated $464,451,235
    • VAN ECK ASSOCIATES CORP added 477,968 shares (+937192.2%) to their portfolio in Q2 2026, for an estimated $141,497,646
    • NORDEA INVESTMENT MANAGEMENT AB added 398,407 shares (+642.4%) to their portfolio in Q2 2026, for an estimated $117,944,408
    • BOSTON PARTNERS removed 317,386 shares (-54.1%) from their portfolio in Q2 2026, for an estimated $93,958,951
    • AQR CAPITAL MANAGEMENT LLC added 313,360 shares (+37.3%) to their portfolio in Q2 2026, for an estimated $92,767,094
    • INVESCO LTD. added 275,743 shares (+22.1%) to their portfolio in Q2 2026, for an estimated $81,630,957

    To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $DPZ Congressional Stock Trading

    Members of Congress have traded $DPZ stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

    See also  Milestone Pharmaceuticals Enrolls First Patient in Phase 3 ReVeRA-301 Trial of Etripamil for AFib-RVR

    Here’s a breakdown of recent trading of $DPZ stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $DPZ Price Targets

    Multiple analysts have issued price targets for $DPZ recently. We have seen 16 analysts offer price targets for $DPZ in the last 6 months, with a median target of $380.0.

    Here are some recent targets:

    • Andrew M. Charles from TD Cowen set a target price of $295.0 on 07/09/2026
    • David Palmer from Evercore ISI Group set a target price of $350.0 on 07/09/2026
    • Lauren Silberman from Deutsche Bank set a target price of $385.0 on 07/09/2026
    • Jon Tower from Citigroup set a target price of $335.0 on 07/07/2026
    • Dennis Geiger from UBS set a target price of $375.0 on 07/02/2026
    • David Tarantino from Baird set a target price of $350.0 on 06/23/2026
    • Peter Saleh from BTIG set a target price of $425.0 on 06/23/2026

    This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.


    Source link

    Author

    Shin John
    Shin JohnYtv Market News
    Share-market news writer and analyst with deep experience covering equities, commodities, forex, and cryptocurrencies for readers in the USA, UK, Canada, and Australia. Ytv Market News delivers timely market updates, practical trading insights, and clear explanations of macro and company-level catalysts that move prices. Combines on-the-ground financial reporting with technical analysis, using concise charts and actionable ideas to help investors and traders make smarter decisions.